首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Health economics review

缩写:

ISSN:2191-1991

e-ISSN:2191-1991

IF/分区:3.4/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引870
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Ijeoma Edoka,Tim Ensor,Barbara McPake et al. Ijeoma Edoka et al.
This study evaluates the impact of Sierra Leone's 2010 Free Health Care Initiative (FHCI). It uses two nationally representative surveys to identify the impact of the policy on utilisation of maternal care services by pregnant women and rec...
K Klose,S Kreimeier,U Tangermann et al. K Klose et al.
With the shift towards patient-centered healthcare, patient- and person-reports of health-related factors, including outcomes, are seen as important determinants for evaluating and improving healthcare. However, a comprehensive, systematic ...
Maria Caballer-Tarazona,Antonio Clemente-Collado,David Vivas-Consuelo Maria Caballer-Tarazona
Public-private partnership (PPP) initiatives are extending around the world, especially in Europe, as an innovation to traditional public health systems, with the intention of making them more efficient.There is a varied range of PPP models...
Sofia Vaz,Pedro Ramos Sofia Vaz
In Portugal, Civil Servants may have a differential utilization of health services due to their supplementary Health Subsystem (ADSE), which grants them access to health services in the private sector at lower price. We exploit the impact o...
Egil Kjerstad,Hanne Kristin Tuntland Egil Kjerstad
Background: In the face of a growing number of older adults in the population, policy-makers in high-income countries are seeking new ways to reduce the expected growth in long-term care expenditure. Research shows that d...
Anthony James Hatswell,Stefan Vegter Anthony James Hatswell
Background: In health economic evaluations, quality of life should be measured with preference-based utilities, such as the EuroQol 5 Dimension 3-level (EQ-5D-3 L). Non-preference-based instruments (often disease-specific...
A ConwayLenihan,S Ahern,S Moore et al. A ConwayLenihan et al.
Background: Pharmaceutical expenditure growth is a familiar feature in many Western health systems and is a real concern for policymakers. A state funded General Medical Services (GMS) scheme in Ireland experienced an inc...
Cagdas Agirdas Cagdas Agirdas
In the early 2000s, Arizona, Maine, New Mexico, New York, Oregon, and Vermont expanded Medicaid to cover more low-income individuals, primarily childless adults. This change provides the researcher with an opportunity to analyze the effects...
Dennis A Ostwald,David Klingenberger Dennis A Ostwald
The perception of the health sector from an economic policy point of view is changing. In the past, health expenditure was mostly seen as a "cost" item, probably because many medical treatments are covered by public health insurance. Howeve...